Key statistics
On Thursday, Lineage Cell Therapeutics Inc (LCTX:ASQ) closed at 0.91, 18.72% above the 52 week low of 0.7665 set on Aug 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.90 |
---|---|
High | 0.91 |
Low | 0.885 |
Bid | 0.8852 |
Offer | 0.9025 |
Previous close | 0.88 |
Average volume | 291.80k |
---|---|
Shares outstanding | 188.84m |
Free float | 188.00m |
P/E (TTM) | -- |
Market cap | 166.18m USD |
EPS (TTM) | -0.1342 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 21:10 BST.
More ▼
- Lineage Presents Preclinical Data on Its Auditory Neuronal Cell Transplant Program, ReSonance™, at the 59th Annual Inner Ear Biology Workshop
- Lineage Cell Therapeutics to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
- Lineage Cell Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
- Lineage Cell Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
- Lineage Cell Therapeutics Added to Membership of 2024 Russell 3000® Index
More ▼